Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

"High Priority" Bar Coding Drugs List Compiled By HDMA

This article was originally published in The Pink Sheet Daily

Executive Summary

Initial bar coding efforts should focus on eight "high-risk" drugs, the Healthcare Distribution Management Association says. The drugs and classes identified are intended to guide initial efforts in complying with FDA's bar coding final rule.

You may also be interested in...



Merck Evaluating Revised Unit-Dose Packaging

According to Institute for Safe Medication Practices' "Medication Safety Alert," Merck is planning a "revamped" system to improve identification of products and strengths.

Merck Evaluating Revised Unit-Dose Packaging

According to Institute for Safe Medication Practices' "Medication Safety Alert," Merck is planning a "revamped" system to improve identification of products and strengths.

FDA Bar Coding Final Rule Sets Two-Year Implementation Timeline For Existing Products

New products approved after April 26 would have to include bar codes on packages within 60 days. The proposed rule would have created a blanket three-year implementation period.

Topics

UsernamePublicRestriction

Register

LL1126230

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel